tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

AI Daily: Nvidia, TSMC unveil first Blackwell wafer produced in U.S.

Catch up on the top artificial intelligence news and commentary by Wall Street analysts on publicly traded companies in the space with this daily recap compiled by The Fly:

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

PRODUCED IN U.S.: Nvidia (NVDA) said it is working together with TSMC (TSM) to celebrate the first Nvidia Blackwell wafer produced on U.S. soil, representing that Blackwell has reached volume production. This bolsters the U.S. supply chain and onshores the AI technology stack that will turn data into intelligence and secure America’s leadership for the AI era, the company said. “This is a historic moment for several reasons. It’s the very first time in recent American history that the single most important chip is being manufactured here in the United States by the most advanced fab, by TSMC, here in the United States,” Nvidia CEO Jensen Huang said. “This is the vision of President Trump of reindustrialization – to bring back manufacturing to America, to create jobs, of course, but also, this is the single most vital manufacturing industry and the most important technology industry in the world.”

FUNDING DISCUSSIONS: AI music generator startup Suno is in discussions to raise over $100M, arriving at a valuation of over $2B, quadrupling its previous valuation, Bloomberg’s Kate Clark, Ashley Carman, and Lucas Shaw report, citing people familiar with the matter. The fundraising comes as Suno and major music labels discuss a settlement pact, the authors note.

BUY TEMPUS AI: Canaccord initiated coverage of Tempus AI (TEM) with a Buy rating and $110 price target. Tempus offers oncology testing for genomic profiling, data services and artificial intelligence applications, the firm tells investors in a research note. Canaccord says the potential of AI deployment at scale in clinical practice could support “strong” long-term revenue growth for Tempus.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1